Peltz's addition should pacify a persistent critique of the company.
Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.
I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.
Aurora's prominent partner could be cannabis' key to breaking into consumer segments.
The plan is for Peltz to help the firm in maximizing potential markets to target.
Themes like cannabis tend to persist longer than many think they will.
The price of ACB is moving up today and a fresh look at the charts and indicators seems like a good idea.
Aurora's addition of a big name activist is accelerating share growth.
This $12 billion industry could rise to around $630 billion over time, according to Seaport analysts.
Potential buyers are faced with a small dilemma here.